Showing results (341-350 of 354) with videos related to
Sort By:
Pageof 36
Bioorganic & Medicinal Chemistry Letters|October 31, 2012
Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2Sharada Labadie, Peter S Dragovich, Kathy Barrett, et al.Bioorganic & Medicinal Chemistry Letters|May 7, 2013
Novel triazolo-pyrrolopyridines as inhibitors of Janus kinase 1Christopher A Hurley, Wade S Blair, Richard J Bull, et al.Bioorganic & Medicinal Chemistry Letters|April 15, 2019
Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signalingMark Zak, Emily J Hanan, Patrick Lupardus, et al.Journal of Medicinal Chemistry|May 18, 2012
Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitorsJanusz J Kulagowski, Wade Blair, Richard J Bull, et al.Global Change Biology|June 12, 2023
Wherever I may roam-Human activity alters movements of red deer (Cervus elaphus) and elk (Cervus canadensis) across two continentsSteffen Mumme, Arthur D Middleton, Paolo Ciucci, et al.The American Journal of Bioethics : AJOB|May 8, 2023
Returning Individual Research Results from Digital Phenotyping in PsychiatryFrancis X Shen, Matthew L Baum, Nicole Martinez-Martin, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Azepines and piperidines with dual norepinephrine dopamine uptake inhibition and antidepressant activityDean G Brown, Peter R Bernstein, Ye Wu, et al.Current Biology : CB|July 4, 2020
Wave-like Patterns of Plant Phenology Determine Ungulate Movement TacticsEllen O Aikens, Atle Mysterud, Jerod A Merkle, et al.Science Translational Medicine|March 11, 2021
A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastomaPriya Kumthekar, Caroline H Ko, Tatjana Paunesku, et al.Journal of Medicinal Chemistry|June 16, 2012
Discovery and optimization of C-2 methyl imidazopyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2Mark Zak, Rohan Mendonca, Mercedesz Balazs, et al.Pageof 36